These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 37703952)
21. Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes. Korshunov A; Okonechnikov K; Schrimpf D; Tonn S; Mynarek M; Koster J; Sievers P; Milde T; Sahm F; Jones DTW; von Deimling A; Pfister SM; Kool M Acta Neuropathol; 2023 Jun; 145(6):829-842. PubMed ID: 37093271 [TBL] [Abstract][Full Text] [Related]
22. METTL3 regulates m Zhang ZW; Teng X; Zhao F; Ma C; Zhang J; Xiao LF; Wang Y; Chang M; Tian Y; Li C; Zhang Z; Song S; Tong WM; Liu P; Niu Y Cell Rep; 2022 Oct; 41(4):111530. PubMed ID: 36288719 [TBL] [Abstract][Full Text] [Related]
23. Signaling pathway and molecular subgroups of medulloblastoma. Li KK; Lau KM; Ng HK Int J Clin Exp Pathol; 2013; 6(7):1211-22. PubMed ID: 23826403 [TBL] [Abstract][Full Text] [Related]
24. Recent advances in SHH medulloblastoma progression: tumor suppressor mechanisms and the tumor microenvironment. Tamayo-Orrego L; Charron F F1000Res; 2019; 8():. PubMed ID: 31700613 [TBL] [Abstract][Full Text] [Related]
25. Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma. Zhu L; Yang Y; Li H; Xu L; You H; Liu Y; Liu Z; Liu X; Zheng D; Bie J; Li J; Song C; Yang B; Luo J; Chang Q Cancer Lett; 2022 Jun; 535():215630. PubMed ID: 35304257 [TBL] [Abstract][Full Text] [Related]
27. Coagulation and angiogenic gene expression profiles are defined by molecular subgroups of medulloblastoma: evidence for growth factor-thrombin cross-talk. D'Asti E; Kool M; Pfister SM; Rak J J Thromb Haemost; 2014 Nov; 12(11):1838-49. PubMed ID: 25163932 [TBL] [Abstract][Full Text] [Related]
28. Signaling pathway and molecular subgroups of medulloblastoma. Int J Clin Exp Pathol. 2013; 6(7): 1211-22. Li KK; Lau KM; Ng HK Int J Clin Exp Pathol; 2015; 8(9):11945. PubMed ID: 26617952 [TBL] [Abstract][Full Text] [Related]
29. Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas. Menyhárt O; Giangaspero F; Győrffy B J Hematol Oncol; 2019 Mar; 12(1):29. PubMed ID: 30876441 [TBL] [Abstract][Full Text] [Related]
30. Sonic hedgehog signaling: Alternative splicing and pathogenic role in medulloblastoma. Qu M; He Q; Luo J; Shen T; Gao R; Xu Y; Xu C; Barkat MQ; Zeng LH; Wu X Genes Dis; 2023 Sep; 10(5):2013-2028. PubMed ID: 37492706 [TBL] [Abstract][Full Text] [Related]
31. Neogenin1 is a Sonic Hedgehog target in medulloblastoma and is necessary for cell cycle progression. Milla LA; Arros A; Espinoza N; Remke M; Kool M; Taylor MD; Pfister SM; Wainwright BJ; Palma V Int J Cancer; 2014 Jan; 134(1):21-31. PubMed ID: 23775842 [TBL] [Abstract][Full Text] [Related]
32. Overcoming resistance to Sonic Hedgehog inhibition by targeting p90 ribosomal S6 kinase in pediatric medulloblastoma. Pambid MR; Berns R; Adomat HH; Hu K; Triscott J; Maurer N; Zisman N; Ramaswamy V; Hawkins CE; Taylor MD; Dunham C; Guns E; Dunn SE Pediatr Blood Cancer; 2014 Jan; 61(1):107-15. PubMed ID: 23940083 [TBL] [Abstract][Full Text] [Related]
33. An ABC Transporter Drives Medulloblastoma Pathogenesis by Regulating Sonic Hedgehog Signaling. Wijaya J; Vo BT; Liu J; Xu B; Wu G; Wang Y; Peng J; Zhang J; Janke LJ; Orr BA; Yu J; Roussel MF; Schuetz JD Cancer Res; 2020 Apr; 80(7):1524-1537. PubMed ID: 31948942 [TBL] [Abstract][Full Text] [Related]
34. Drug Delivery Systems for Hedgehog Inhibitors in the Treatment of SHH-Medulloblastoma. Caimano M; Lospinoso Severini L; Loricchio E; Infante P; Di Marcotullio L Front Chem; 2021; 9():688108. PubMed ID: 34164380 [TBL] [Abstract][Full Text] [Related]
35. Potential use of CXCL12/CXCR4 and sonic hedgehog pathways as therapeutic targets in medulloblastoma. Amarante MK; Vitiello GAF; Rosa MH; Mancilla IA; Watanabe MAE Acta Oncol; 2018 Sep; 57(9):1134-1142. PubMed ID: 29771176 [TBL] [Abstract][Full Text] [Related]
36. Phase I and phase II sonidegib and vismodegib clinical trials for the treatment of paediatric and adult MB patients: a systemic review and meta-analysis. Li Y; Song Q; Day BW Acta Neuropathol Commun; 2019 Jul; 7(1):123. PubMed ID: 31362788 [TBL] [Abstract][Full Text] [Related]